The current stock price of THRM is 35.67 USD. In the past month the price decreased by -2.54%. In the past year, price decreased by -15.27%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| BWA | BORGWARNER INC | 9.42 | 9.21B | ||
| MOD | MODINE MANUFACTURING CO | 38.97 | 8.54B | ||
| QS | QUANTUMSCAPE CORP | N/A | 7.35B | ||
| LEA | LEAR CORP | 8.71 | 5.57B | ||
| GNTX | GENTEX CORP | 12.83 | 5.00B | ||
| DORM | DORMAN PRODUCTS INC | 14.86 | 4.04B | ||
| PATK | PATRICK INDUSTRIES INC | 26.79 | 3.60B | ||
| DAN | DANA INC | 14.46 | 2.62B | ||
| VC | VISTEON CORP | 9.07 | 2.82B | ||
| LCII | LCI INDUSTRIES | 15.16 | 2.75B | ||
| PHIN | PHINIA INC | 11.99 | 2.08B | ||
| XPEL | XPEL INC | 27.5 | 1.29B |
Gentherm, Inc. engages in the design, development, manufacturing, and marketing of heating, cooling, and ventilating devices. The company is headquartered in Novi, Michigan and currently employs 14,246 full-time employees. The firm operates in two segments: Automotive and Medical. The Automotive reporting segment comprises global automotive businesses, including the design, development, manufacturing and sales of its automotive climate and comfort solutions (including Climate Control Seats, Climate Control Interiors, lumbar and massage comfort solutions and electronic solutions for climate and comfort technologies), valve system solutions and other automotive products. The Medical reporting segment comprises the patient temperature management business in the medical industry. Patient temperature management includes temperature management systems across multiple product categories addressing the needs of hyper-hypothermia therapy in intensive care, normothermia in surgical procedures and additional warming/cooling therapies utilized in acute and chronic care departments and non-hospital facilities.
GENTHERM INC
28875 Cabot Drive
Novi MICHIGAN 48167 US
CEO: PHILLIP EYLER
Employees: 14246
Phone: 12485040500
Gentherm, Inc. engages in the design, development, manufacturing, and marketing of heating, cooling, and ventilating devices. The company is headquartered in Novi, Michigan and currently employs 14,246 full-time employees. The firm operates in two segments: Automotive and Medical. The Automotive reporting segment comprises global automotive businesses, including the design, development, manufacturing and sales of its automotive climate and comfort solutions (including Climate Control Seats, Climate Control Interiors, lumbar and massage comfort solutions and electronic solutions for climate and comfort technologies), valve system solutions and other automotive products. The Medical reporting segment comprises the patient temperature management business in the medical industry. Patient temperature management includes temperature management systems across multiple product categories addressing the needs of hyper-hypothermia therapy in intensive care, normothermia in surgical procedures and additional warming/cooling therapies utilized in acute and chronic care departments and non-hospital facilities.
The current stock price of THRM is 35.67 USD.
THRM does not pay a dividend.
THRM has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
12 analysts have analysed THRM and the average price target is 46.51 USD. This implies a price increase of 30.4% is expected in the next year compared to the current price of 35.67.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on THRM.
GENTHERM INC (THRM) currently has 14246 employees.
ChartMill assigns a technical rating of 3 / 10 to THRM. When comparing the yearly performance of all stocks, THRM is a bad performer in the overall market: 74.31% of all stocks are doing better.
ChartMill assigns a fundamental rating of 4 / 10 to THRM. THRM has a great financial health rating, but its profitability evaluates not so good.
Over the last trailing twelve months THRM reported a non-GAAP Earnings per Share(EPS) of 2.07. The EPS decreased by -29.35% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 2.06% | ||
| ROA | 2.19% | ||
| ROE | 4.22% | ||
| Debt/Equity | 0.26 |
12 analysts have analysed THRM and the average price target is 46.51 USD. This implies a price increase of 30.4% is expected in the next year compared to the current price of 35.67.
For the next year, analysts expect an EPS growth of 5.3% and a revenue growth 1% for THRM